Faults abound for Medicare Part D's oversight

07/2/2013 | ProPublica

Following an investigation in May by ProPublica of oversight of Medicare's Part D prescription drug program, a number of things have happened, including Senate hearings, a follow-up ProPublica investigation of ties between industry-paid speaking fees for doctors and drugs they prescribe, and a pair of reports from the inspector general of HHS further highlighting the issues in the Part D program.

View Full Article in: